{"id":479,"date":"2026-08-28T06:56:06","date_gmt":"2026-08-28T06:56:06","guid":{"rendered":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/"},"modified":"2026-08-28T07:42:46","modified_gmt":"2026-08-28T07:42:46","slug":"cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/","title":{"rendered":"CJC-1295 Mit DAC: Albuminbindung, Identit\u00e4tskontrollen und FDA-Sicherheitskontext"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">F\u00fcr CJC-1295 mit DAC ist die Albumin-reaktive Gruppe kein Markendetail. Es ver\u00e4ndert die Persistenz, das Analyseverhalten und die Relevanz der ver\u00f6ffentlichten menschlichen Daten.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Was die Aufzeichnung zeigt<\/h2><ul class=\"wp-block-list\"><li>Mit-DAC- und ohne-DAC-Materialien sollten getrennte Produktfamilien bleiben.<\/li><li>FDA weist auf Bedenken bez\u00fcglich Immunogenit\u00e4t, Peptidverunreinigung und API-Charakterisierung hin.<\/li><li>Ein Massenergebnis allein kann reaktive oder Albumin-assoziierte Spezies m\u00f6glicherweise nicht vollst\u00e4ndig charakterisieren.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Wissenschaftler \u00fcberpr\u00fcft Forschungsdaten zu pulsierendem Wachstumshormon und IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Originale redaktionelle Illustration zur Identifizierung des Forschungsthemas. Es stellt keine Katalogcharge, kein zugelassenes Medikament, kein Testergebnis oder keine klinische Verwendung dar.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Die Identit\u00e4ts- und Beweisgrenze<\/h2><p class=\"wp-block-paragraph\">Das Zertifikat sollte die genaue Sequenz, die DAC-bezogene Modifikation, die molekulare Form und den analytischen Ansatz angeben. Die allgemeine Formulierung \u201eCJC Reinheit\u201c reicht nicht aus, um das langwirksame Material zu unterscheiden.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Definierendes Merkmal<\/strong><span>Wirkstoffaffinit\u00e4tskomplexgruppe zur Albuminbindung<\/span><\/div><div class=\"pim-evidence-row\"><strong>Ver\u00f6ffentlichte Halbwertszeit<\/strong><span>5.8\u20138.1 Tage in der fr\u00fchen Humanstudie<\/span><\/div><div class=\"pim-evidence-row\"><strong>Aktueller FDA-Kontext<\/strong><span>Begrenzte klinische Daten und gemeldete schwerwiegende unerw\u00fcnschte Ereignisse<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Was in die Materialakte geh\u00f6rt<\/h2><p class=\"wp-block-paragraph\">Die Beweiskopie sollte die fr\u00fchen pharmakodynamischen Erkenntnisse mit der aktuellen FDA-Sicherheitssprache in Einklang bringen. Keine der Quellen validiert ein bestimmtes Kataloglos.<\/p><h2 class=\"wp-block-heading\">Redaktionelle Regel<\/h2><p class=\"wp-block-paragraph\">Verwenden Sie den genauen Interventionsnamen, das Modell, die Population und den Endpunkt aus dem zitierten Datensatz. Wandeln Sie eine Assoziation, einen Mechanismus, ein Tierergebnis, eine genehmigte Fertigarzneimittelaufzeichnung oder einen analytischen Test nicht in einen Anspruch \u00fcber eine nicht verwandte Katalogcharge um.<\/p><p class=\"wp-block-paragraph\"><strong>FDA Quellbereich:<\/strong> In der FDA-Massensicherheitszusammenfassung wird \u201eCJC-1295\u201c allgemein aufgef\u00fchrt und in dieser Zeile werden DAC und \u201eohne-DAC\u201c nicht aufgel\u00f6st. Es sollte nicht allein als formspezifischer Kausalit\u00e4tsbeweis verwendet werden.<\/p>","protected":false},"excerpt":{"rendered":"<p>F\u00fcr CJC-1295 mit DAC ist die Albumin-reaktive Gruppe kein Markendetail. Es ver\u00e4ndert die Persistenz, das Analyseverhalten und die Relevanz der ver\u00f6ffentlichten menschlichen Daten.<\/p>","protected":false},"author":1,"featured_media":644,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"322","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Human PK\/PD data plus FDA safety and characterization review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"CJC-1295 prolonged GH and IGF-1 stimulation in healthy adults\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16352683\/\",\"note\":\"Primary human PK\/PD study; PMID 16352683.\"},{\"title\":\"CJC-1295 and preserved GH pulsatility\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17018654\/\",\"note\":\"Mechanistic human follow-up; PMID 17018654.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current CJC-1295 safety summary.\"},{\"title\":\"ICH Q2(R2): Validation of Analytical Procedures\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q2%28R2%29_Guideline_2023_1130.pdf\",\"note\":\"Official analytical-validation framework; not evidence that a specific catalog lot has been tested.\"},{\"title\":\"ICH Q14: Analytical Procedure Development\",\"url\":\"https:\/\/database.ich.org\/sites\/default\/files\/ICH_Q14_Guideline_2023_1116.pdf\",\"note\":\"Official analytical-development framework; included as general method guidance only.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-479","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context - NHD<\/title>\n<meta name=\"description\" content=\"For CJC-1295 with DAC, the albumin-reactive group is not a branding detail. It changes persistence, analytical behavior and the relevance of the published\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context\" \/>\n<meta property=\"og:description\" content=\"For CJC-1295 with DAC, the albumin-reactive group is not a branding detail. It changes persistence, analytical behavior and the relevance of the published\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:42:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:42:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/\",\"name\":\"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:06+00:00\",\"dateModified\":\"2026-08-28T07:42:46+00:00\",\"description\":\"For CJC-1295 with DAC, the albumin-reactive group is not a branding detail. It changes persistence, analytical behavior and the relevance of the published\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"CJC-1295 Mit DAC: Albuminbindung, Identit\u00e4tskontrollen und FDA-Sicherheitskontext \u2013 NHD","description":"F\u00fcr CJC-1295 mit DAC ist die Albumin-reaktive Gruppe kein Markendetail. Es ver\u00e4ndert die Beharrlichkeit, das Analyseverhalten und die Relevanz der ver\u00f6ffentlichten\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/","og_locale":"de_DE","og_type":"article","og_title":"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context","og_description":"For CJC-1295 with DAC, the albumin-reactive group is not a branding detail. It changes persistence, analytical behavior and the relevance of the published\u2026","og_url":"https:\/\/nhdbio.com\/de\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:06+00:00","article_modified_time":"2026-08-28T07:42:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:42:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/","url":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/","name":"CJC-1295 Mit DAC: Albuminbindung, Identit\u00e4tskontrollen und FDA-Sicherheitskontext \u2013 NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:06+00:00","dateModified":"2026-08-28T07:42:46+00:00","description":"F\u00fcr CJC-1295 mit DAC ist die Albumin-reaktive Gruppe kein Markendetail. Es ver\u00e4ndert die Beharrlichkeit, das Analyseverhalten und die Relevanz der ver\u00f6ffentlichten\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/cjc-1295-dac-albumin-binding-identity-and-fda-safety-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"CJC-1295 With DAC: Albumin Binding, Identity Controls and FDA Safety Context"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=479"}],"version-history":[{"count":2,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/479\/revisions"}],"predecessor-version":[{"id":534,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/479\/revisions\/534"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/644"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=479"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}